General AML, TP53, FLT3, & 1 more
Lars Bullinger | EHA 2018 | What are the clinical implications of mutations in AML?
Cynthia Umukoro , Jun 18, 2018
General AML, IDH1/2
Julie Bergeron | EHA 2018 | What are the latest emerging novel approaches for treatment in AML?
Julie Bergeron , Jun 17, 2018